Human Vaccines & Immunotherapeutics

Papers
(The H4-Index of Human Vaccines & Immunotherapeutics is 39. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-10-01 to 2025-10-01.)
ArticleCitations
Single-cell analysis unravels the role of NK cells and monocytes in the control of SARS-CoV-2 breakthrough infections in vaccinated individuals339
Immunological non-inferiority and safety of a quadrivalent inactivated influenza vaccine versus two trivalent inactivated influenza vaccines in China: Results from two studies291
Health, beliefs, and faith: HPV vaccine uptake intent among Catholic, Evangelical, and mainline protestant parents175
Understanding barriers to influenza vaccination among parents is important to improve vaccine uptake among children155
Enhancing COVID-19 booster vaccination among the elderly through text message reminders110
Childhood vaccination uptake among children born in Aotearoa New Zealand based on parental nationality78
Immunogenicity and safety of human diploid cell vaccine (HDCV) vs. purified Vero cell vaccine (PVRV) vs. purified chick embryo cell vaccine (PCECV) used in post-exposure prophylaxis: a systematic revi77
Pertactin deficiency of Bordetella pertussis : Insights into epidemiology, and perspectives on surveillance and public health impact76
Medical students’ knowledge about human papillomavirus (HPV), HPV vaccine and head and neck cancer72
Long-term follow up of patients treated with a DNA vaccine (pTVG-hp) for PSA-recurrent prostate cancer67
Determinants of basic childhood vaccination coverage in European and OECD countries63
The prevalence and determinants of COVID-19 vaccine hesitancy in the age of infodemic63
Implementing interventions to start HPV vaccination at age 9: Using the evidence we have63
Challenges to COVID-19 vaccine introduction in the Democratic Republic of the Congo – a commentary60
Safety and immunogenicity of quadrivalent meningococcal polysaccharide vaccine (MPV ACYW135) compared with quadrivalent meningococcal conjugate vaccine (Menactra®) in Malian children59
Efficiency enhancement in main path extraction in mRNA vaccine field: A novel approach leveraging intermediate patents, with shielding origin and terminus patent edges59
Associations between vaccination clinic factors and DTaP dropout in China: A cross-sectional study58
Geographical and time trends of measles incidence and measles vaccination coverage and their correlation in Nigeria58
Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine administered in a prime-boost regimen among Chinese infants: a randomized, double blind phase III clinical trial57
Modeled impact of the COVID-19 pandemic and associated reduction in adult vaccinations on herpes zoster in the United States57
Community based participatory research as a promising practice for addressing vaccine hesitancy, rebuilding trust and addressing health disparities among racial and ethnic minority communities56
Review of the epidemiology, diagnosis and management of invasive meningococcal disease in Vietnam54
Correction54
Estimation of single-dose varicella vaccine effectiveness in South Korea using mathematical modeling52
Booster vaccines dose reduced mortality in hospitalized COVID-19 patients requiring oxygen supplementation: Evidence from the Beijing Omicron outbreak52
Factors influencing COVID-19 vaccine acceptance and hesitancy: Correspondence51
Plasma therapy: a passive resistance against the deadliest50
The public health impact of recombinant herpes zoster vaccination in adults over 50 years in Spain50
Human vaccines & immunotherapeutics: News October 202249
Systematic literature review and meta-analysis on the prevalence of rotavirus genotypes in Asia from 2015 to 202148
Willingness of college students to receive COVID-19 heterologous vaccination in Taizhou, China47
COVID-19 vaccine acceptance and hesitancy among ethnic minorities in Hong Kong46
Assessment of COVID-19 vaccine take-up and its predictors among healthcare professionals in public hospitals, Addis Ababa, Ethiopia: Facility-based cross-sectional study46
Vaccine manufacturing is essential to ensure access45
Response to a letter to the editor regarding ‘ the comparison of seroconversion rates among different varicella vaccines administered Turkish children; MAV/06 and vOka’45
Impact of propensity to COVID-19 vaccination/vaccine on influenza vaccination from willingness to behavior among older adults in rural China45
Human vaccines & immunotherapeutics: news October 202144
Improving Tdap maternal immunization rate in Saudi Arabia41
HV&I Reviewer Highlight41
0.084699869155884